$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
MicroRNAs (miRNAs) are short non-coding RNA molecules that significantly influence gene expression by acting at the post-transcriptional stage1. They typically function by binding to complementary sequences in the 3' untranslated regions (UTRs) of target messenger RNAs (mRNAs), leading to mRNA degradation or translational repression1. Over the past two decades, miRNAs have been increasingly recognized as central regulators of various biological processes, including cell proliferation, differentiation, apoptosis, immune responses, and organ development2. Moreover, dysregulation of miRNA expression has been implicated in the pathogenesis of numerous diseases, such as cancer, cardiovascular disease, neurological disorders, and kidney disease3. These findings highlight the potential of miRNAs not only as therapeutic targets but also as minimally invasive biomarkers in clinical diagnostics.
With the advent of next-generation sequencing (NGS) technologies, the study of miRNAs has entered a new era. Unlike microarray-based methods that are limited to known miRNAs, miRNA sequencing (miRNA-Seq) enables comprehensive, high-throughput, and unbiased profiling of both known and novel miRNAs across different sample types and conditions4. miRNA-Seq provides superior sensitivity, accuracy, and dynamic range, making it a preferred method for investigating miRNA expression patterns and discovering regulatory mechanisms in physiological and pathological settings5. However, the analysis of miRNA-Seq data presents specific computational challenges, including the handling of short read lengths, removal of adapter sequences, distinguishing between closely related miRNA family members, and managing high redundancy in read counts6. These characteristics necessitate a carefully designed and standardized analytical workflow.
Although various pipelines and software tools have been developed for miRNA-Seq data analysis, many of them rely on graphical user interfaces or fixed workflows that limit flexibility and reproducibility7. In contrast, the R programming environment provides a powerful and customizable platform for bioinformatics analysis8. R offers a rich ecosystem of packages for statistical modeling, data visualization, and integration with biological databases. This enables users to perform comprehensive and reproducible analyses in a transparent and script-based manner. Moreover, the modular nature of R workflows allows researchers to tailor each step according to specific experimental requirements, from raw data preprocessing to functional interpretation.
In this protocol, we present a verified and complete miRNA-Seq analysis workflow implemented entirely in R, with the goal of providing a reproducible and user-adaptable solution for researchers working with miRNA expression data. The workflow begins with quality control and adapter trimming of raw sequencing reads, followed by alignment to a reference genome or known miRNA sequences. Subsequent steps include quantification of read counts, normalization, differential expression analysis, target gene prediction, functional enrichment, and network visualization. The workflow incorporates several widely used and well-maintained R packages, ensuring both reliability and compatibility with future updates and extensions.
One of the core strengths of this protocol lies in its ability to move beyond differential expression results and provide meaningful biological interpretation. By integrating curated databases of validated and predicted miRNA-mRNA interactions, the workflow allows users to identify biologically relevant target genes. These targets can then be subjected to Gene Ontology and pathway enrichment analyses to uncover affected biological processes and molecular pathways. In the final step, miRNA-mRNA interaction networks can be visualized using external tools such as Cytoscape9, providing insight into the regulatory landscape and identifying key hub miRNAs with potential functional importance.
This method has been successfully applied in clinical research contexts, including studies on kidney disease, where circulating miRNAs serve as promising biomarkers for diagnosis and prognosis10. However, the modular and flexible design of the workflow makes it suitable for a wide range of applications, including disease modeling, drug response studies, developmental biology, and comparative genomics. Researchers can easily adapt the workflow to accommodate species-specific annotations, experimental conditions, or additional layers of omics data.
By offering an open-source, script-based solution, this R-centered pipeline addresses several of the major limitations associated with existing miRNA-Seq tools, including limited customization, reliance on non-transparent graphical interfaces, lack of support for non-model organisms, poor reproducibility due to the absence of version control, and difficulty in integrating with downstream statistical and functional analysis frameworks. It enables full control over data processing parameters, encourages reproducibility through version-controlled code, and promotes transparency in bioinformatics research. As the importance of miRNAs continues to grow in the context of systems biology and translational medicine, having access to a reliable and adaptable analysis framework becomes increasingly essential.